Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 78 results found. Search for [ Covishield ]

Results 1 to 21 of 78
Reuters
December 3, 2020
The new purchase is part of a US government deal to secure nearly 1 million doses of Lilly's bamlanivimab


PTI
December 3, 2020
The total coronavirus cases mounted to 95,34,964 with 35,551 new infections being reported in a day, while the death toll climbed to 1,38,648 with 526 new fatalities


BusinessToday.In
December 3, 2020
'The exams as and when they are being conducted, will be in the written mode and not in online mode. The exams will be conducted following all COVID protocols,' CBSE said in a statement


BusinessToday.In
December 3, 2020
Serum Institute's chief executive officer, Adar Poonawalla, has confirmed that the company's coronavirus vaccine will enter the open market post-March to April 2021 if the vaccine is found to be 'immunogenic and safe'


BusinessToday.In
December 2, 2020
Everyday, more than 20 million user contributions are received by the application, and Google Maps is launching this feature after having reorganising the plethora of data.


BusinessToday.In
December 2, 2020
Union health secretary Rajesh Bhushan says the adverse event during recent clinical trials will not affect the timelines in any manner whatsoever


BusinessToday.In
December 1, 2020
Deputy Commissioner of Police of Outer North Range, however, told the news portal that \"no detention had taken place\" and that police personnel had found it their duty to accompany the \"senior citizen\" to safety.


PTI
December 1, 2020
A 40-year-old man who was a volunteer in the third phase of the ''Covidshield'' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions


BusinessToday.In
December 1, 2020
Balram Bhargava, Director General of Indian Council of Medical Research (ICMR), said that the primary objective of vaccination is to break the COVID-19 transmission chain


BusinessToday.In
December 1, 2020
The plans offer coverage under two different conditions, the first being one where job/income is lost due to termination/lay-off or retrenchment, and the second condition is where job/income is lost due to disability or death


BusinessToday.In
December 1, 2020
Justin Trudeau's comment has not gone well with both the ruling Bharatiya Janata Party and Aam Aadmi Party. External Affairs Ministry Spokesperson Anurag Srivastava called Trudeau's remarks as 'ill-informed' and 'unwarranted'


BusinessToday.In
December 1, 2020
The trial will run for 12 months until December next year. Unilever said the employees will be paid for five days while working for just four days


BusinessToday.In
December 1, 2020
In a statement, SII said the incident with the Chennai volunteer, though highly unfortunate, was in no way induced by the vaccine and that SII is sympathetic with the volunteer's medical condition


BusinessToday.In
November 29, 2020
A 40-year-old Chennai-based man had alleged that he suffered serious side effects following vaccination and sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial


PTI
November 29, 2020
The legal notice has been sent to Pune based Serum Institute of India, which has collaborated with Oxford University and Astra Zeneca, a pharmaceutical company, in connection with making of the vaccine, 'Covidshield.'


BusinessToday.In
November 29, 2020
Poonawallathanks PM Modi for visiting the institute; says SII shares his vision and continues to work towards ensuring a safe and secure India. SII may apply for emergency use authorisation of its vaccine in the next two weeks


BusinessToday.In
November 29, 2020
Serum Institute of India's (SII) CEO Adar Poonawalla made the announcement hours after a meeting with Prime Minister Narendra Modi, who visited Serum's plant in Pune on Saturday, November 28


PB Jayakumar
November 28, 2020
Serum Institute will have a capacity to make over 2.5 billion doses of vaccines a year as it is currently upscaling the capacity from over 1.6 billion doses  


PB Jayakumar
November 28, 2020
Prime Minister Narendra Modi's visit to these facilities and discussions with the scientists are to help him get a first-hand perspective of the preparations, challenges and roadmap in India's vaccination plans


BusinessToday.In
November 27, 2020
The company could be looking at manufacturing 100 million doses to begin with, as per Chairman Pankaj Patel.


PAGES 1 OF 4  1234